Merck KGaA Stock

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra 11:35:29 2024-05-17 EDT 5-day change 1st Jan Change
167.2 EUR -0.89% Intraday chart for Merck KGaA +7.52% +16.03%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 21.25B 23.09B 31.42B Sales 2025 * 22.47B 24.42B 33.23B Capitalization 72.69B 79B 107B
Net income 2024 * 2.98B 3.24B 4.41B Net income 2025 * 3.48B 3.78B 5.14B EV / Sales 2024 * 3.42 x
Net cash position 2024 * - 0 0 Net Debt 2025 * 4.49K 4.88K 6.64K EV / Sales 2025 * 3.24 x
P/E ratio 2024 *
24.1 x
P/E ratio 2025 *
20.5 x
Employees 62,345
Yield 2024 *
1.36%
Yield 2025 *
1.45%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.89%
1 week+7.52%
Current month+12.25%
1 month+13.94%
3 months+7.39%
6 months+6.53%
Current year+16.03%
More quotes
1 week
154.20
Extreme 154.2
169.05
1 month
146.10
Extreme 146.1
169.05
Current year
140.50
Extreme 140.5
169.05
1 year
134.30
Extreme 134.3
172.40
3 years
134.30
Extreme 134.3
231.50
5 years
76.22
Extreme 76.22
231.50
10 years
61.05
Extreme 61.05
231.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 20-07-12
Director of Finance/CFO 56 14-07-31
Director of Finance/CFO 53 19-04-25
Members of the board TitleAgeSince
Director/Board Member 75 14-05-08
Director/Board Member - -
Chairman 67 19-04-25
More insiders
Date Price Change Volume
24-05-17 167.2 -0.89% 286,898
24-05-16 168.7 +1.72% 498,812
24-05-15 165.8 +4.77% 741,893
24-05-14 158.3 +2.46% 298,795
24-05-13 154.5 -0.64% 235,637

Delayed Quote Xetra, May 17, 2024 at 11:35 am

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
167.2 EUR
Average target price
182.3 EUR
Spread / Average Target
+9.04%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW